Megluflor Injectable Solution
ميغلوفلور محلول للحقن
Megluflor Injectable Solution is a combination antimicrobial and anti-inflammatory injection containing Florfenicol (300 mg/ml) and Flunixin meglumine (equivalent to 16.5 mg Flunixin base) for bovine respiratory disease (BRD) in cattle.
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Cattle | 6 ml per 45 kg body weight (40 mg florfenicol + 2.2 mg flunixin / kg b.wt) | Subcutaneous | Single dose |
Withdrawal Periods
| Species | Meat (days) | Milk (days) | Eggs (days) |
|---|---|---|---|
| Cattle | 46 |
Indications
-
Treatment of bovine respiratory disease (BRD) in cattle associated with Pasteurella multocida, Mannheimia haemolytica, and Mycoplasma bovis with associated pyrexia and inflammation.
Contraindications
-
Hypersensitivity to active ingredients. Do not use in animals suffering from hepatic, renal, or cardiac disease. Prohibited in lactating cattle producing milk for human consumption.
Precautions
No precautions information available.
Side Effects
-
Swelling at the injection site after subcutaneous administration.
Images
Documents
-
Download
Official Pharma Swede Product Specification
Datasheet
Active Ingredients
-
Florfenicol
300 mg/ml
-
Flunixin
17 mg/ml
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
Companies
-
Pharma Swede Egypt
Manufacturer
Alternatives
No alternatives available.